NEWBORN DRUG TESTING
Newborn Drug & Alcohol Testing
Specimen: Umbilical Cord Tissue
Turnaround time: 24-48 hours (full report including confirmation results)
​
Neonatal abstinence syndrome (NAS) is a group of conditions that develop in newborns who received opioids or other addictive substances while in the womb, commonly associated with maternal drug use. Withdrawal symptoms typically occur shortly after birth when the newborn is no longer getting the drug.
Symptoms vary and can include trembling, crying, seizures, vomiting, sweating, and unstable temperature. In addition to the withdrawal symptoms more serious complications can include, poor growth in the uterus, birth defects, seizure, developmental delay, premature birth and stillbirth.
Treatment methods are available to assist in the withdrawal process and depend on factors such as the type of drug, severity, age and general health of the newborn.
Toxicology tests with screening done by EMIT and confirmation by LC-MS/MS technology
Patients Choice Advantage
-
Results in 24-48 hours including confirmatory
​
-
Competitive Pricing
​
-
20 week detection window
​
-
Confirmatory testing by LC-MS/MS
​
-
Industry leading low cutoffs
​
-
Rare offerings including Fentanyl & Analogs, Xylazine, Xylazine
​
-
Performs d/l isomer and EtG/EtS testing on location
​
-
Detailed color-coded reports
DRAMATIC INCREASE IN
MATERNAL DRUG USE AND NAS
24 Minutes
Every 24 minutes a baby is diagnosed in the United States with NAS. That's more than 59 newborns everyday.
82%
National increase from 2010 to 2017 in number of babies born with NAS.
Average Length and Cost of Hospital Stay
​
Diabetic foot wound infections are often resistant to traditional antimicrobial treatments and, due to the immunocompromised nature of such individuals, can actually increase the risk of certain infections.¹
​
Pressure ulcers can be a major source of infection and lead to many other complications. 2.5 million people are treated for pressure ulcers in acute care facilities in the US alone.2
​
A death every 15 minutes.
In 2019, 2.8 millions infections and 35,000 deaths in the United States alone, were caused by antibiotic-resistance bacteria and fungi.4 This number could exceed 10 million people worldwide by 2050 if more isn’t done to stem antibiotic resistance.5